ACE Report Cover
Peri-Articular Corticosteroid Injection Improves Pain 1-Day vs Intravenous Injection in TKA
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
Peri-Articular Corticosteroid Injection Improves Pain 1-Day vs Intravenous Injection in TKA .
Verified
This report has been verified by one or more authors of the original publication.

Comparison of Intravenous and Periarticular Administration of Corticosteroids in Total Knee Arthroplasty: A Prospective, Randomized Controlled Study

J Bone Joint Surg Am. 2021 Feb 17;103(4): 319-325

One hundred patients with knee osteoarthritis (OA) scheduled for a unilateral total knee arthroplasty (TKA) were randomized to receive an intra-articular injection of dexamethasone (n=50) or peri-articular injection of triamcinolone acetonide (n=50). Outcomes of interest included the following: pain which was evaluated using the Numeric Rating Scale (NRS) at rest and during walking, nausea measured on NRS, incidence of vomiting, mean number of uses of rescue analgesia, number of patients with a fever, and mean number of uses of metoclopramide. Furthermore, inflammatory and serum markers were measured including levels of interleukin-6 (IL-6), C-reactive protein (CRP), and prothrombin fragment 1.2 (PF1.2), fasting blood glucose, and D-dimer. Pain at rest was measured at 4, 8, 16, 24, 48, and 72 hours and 1 week follow-up whereas pain during walking was measured at 24, 48, and 72 hours and 1 week follow-up. The number of uses of metoclopramide and rescue analgesia, and the incidence of vomiting were measured at 24-hours post-surgery. Nausea severity on a NRS was measured at 8, 24, and 48 hours post-surgery. Levels of IL-6 and CRP were measured at 24 and 48 hours, and CRP was measured at 1 week follow-up. Lastly, PF1.2 was only evaluated at 4 hours whereas D-dimer was measured at 24 and 48 hours and 1 week post-surgery. Results revealed that mean NRS pain during rest and pain during walking at 24 hours were statistically significantly reduced in the peri-articular injection group compared to the intravenous injection group(p<0.01 for both). Also, PF1.2 was also statistically significantly higher in the peri-articular injection group vs. the intravenous injection group at 4 hours post-surgery (p=0.006). CRP levels were statistically significantly lower in the intravenous injection group at 24 and 48 hours post-surgery, but statistically significantly higher at 1 week follow-up when compared to the peri-articular injection group (p<0.05 for all). All other outcomes at all other timepoints were not statistically significantly different between the 2 groups (p>0.05 for all). Two cases of deep vein thrombosis were observed in each arm, and no incidence of infection or delayed wound healing were observed in either group.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Peri-Articular Corticosteroid Injection Improves Pain 1-Day vs Intravenous Injection in TKA. ACE Report. 2021;11(1):5. Available from: https://myorthoevidence.com/AceReport/Show/peri-articular-corticosteroid-injection-improves-pain-1-day-vs-intravenous-injection-in-tka

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report